SCHEMBL842728

SCHEMBL842728

O=P(O)(O)Oc1cccc(O)c1O

nearest known ligand 0.63

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
INPPL1 O15357 8/20 0.63
INPP5A Q14642 5/20 0.63
INPP5B P32019 2/20 0.63
SRC P12931 5/20 0.50
ALDH1A1 P00352 3/20 0.50
HPGD P15428 3/20 0.50
HSD17B10 Q99714 3/20 0.50
KDM4E B2RXH2 2/20 0.50
LMNA P02545 2/20 0.50
ALOX15 P16050 2/20 0.50
TP53 P04637 1/20 0.50
CYP3A4 P08684 1/20 0.50
MAPT P10636 1/20 0.50
ALOX12 P18054 1/20 0.50
MAPK1 P28482 1/20 0.50
AKT1 P31749 1/20 0.50
USP2 O75604 1/20 0.50
PDE3A Q14432 1/20 0.50
ADAMTS4 O75173 1/20 0.46
EGFR P00533 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28415999 0.87 ALDH1A1 (0.50) INPPL1INPP5AINPP5BSRCALDH1A1
SCHEMBL522291 0.84 INPPL1 (0.59) INPPL1INPP5AINPP5BSRCALDH1A1
SCHEMBL29655758 0.84 INPPL1 (0.59) INPPL1INPP5AINPP5BSRCALDH1A1
Ammonia Solution, Strong SCHEMBL11748950 0.83 INPPL1 (0.57) INPPL1INPP5AINPP5BSRCALDH1A1
SCHEMBL28895404 0.83 INPPL1 (0.57) INPPL1INPP5AINPP5BSRCALDH1A1
SCHEMBL3093492 0.83 INPPL1 (0.56) INPPL1INPP5AINPP5BSRCALDH1A1
SCHEMBL8384662 0.82 INPPL1 (0.57) INPPL1INPP5AINPP5BSRCALDH1A1
SCHEMBL5606361 0.81 INPPL1 (0.43) INPPL1INPP5AINPP5BSRCALDH1A1
SCHEMBL466513 0.79 GABRA1 (0.55) INPPL1INPP5AINPP5BSRCALDH1A1
SCHEMBL19738122 0.79 SRC (0.56) INPPL1INPP5AINPP5BSRCALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 18 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-116694285-B High-modulus flame-retardant MS adhesive and preparation method thereof 信泰永合(烟台)新材料有限公司 2023-11-03 CN claimed
CN-116694285-A High-modulus flame-retardant MS adhesive and preparation method thereof 信泰永合(烟台)新材料有限公司 2023-09-05 CN claimed
EP-2722101-B1 REVERSE-OSMOSIS MEMBRANE HAVING AN ULTRA-HYDROPHILIC PROTECTIVE LAYER AND METHOD FOR PRODUCING SAME LG CHEMICAL LTD (KR) 2018-10-24 EP claimed
US-8770414-B2 Reverse osmosis membrane including ultra-hydrophilic passivation layer and method of manufacturing the same LG CHEM, LTD. (KR) 2014-07-08 US claimed
EP-2722101-A2 REVERSE-OSMOSIS MEMBRANE HAVING AN ULTRA-HYDROPHILIC PROTECTIVE LAYER AND METHOD FOR PRODUCING SAME LG Chem, Ltd. (KR) 2014-04-23 EP claimed
US-20130284663-A1 REVERSE OSMOSIS MEMBRANE INCLUDING ULTRA-HYDROPHILIC PASSIVATION LAYER AND METHOD OF MANUFACTURING THE SAME LG CHEM, LTD. (KR) 2013-10-31 US claimed
US-8142953-B2 Hydrophilic adjuvant LG CHEM, LTD. (KR) 2012-03-27 US claimed
US-20100167168-A1 Hydrophilic Adjuvant LG CHEM, LTD. (KR) 2010-07-01 US claimed
WO-2007069867-A1 HYDROPHILIC ADJUVANT LG CHEM, LTD (KR) 2007-06-21 WO claimed
CN-116694285-B High-modulus flame-retardant MS adhesive and preparation method thereof 信泰永合(烟台)新材料有限公司 2023-11-03 CN disclosed
CN-116694285-A High-modulus flame-retardant MS adhesive and preparation method thereof 信泰永合(烟台)新材料有限公司 2023-09-05 CN disclosed
EP-2722101-B1 REVERSE-OSMOSIS MEMBRANE HAVING AN ULTRA-HYDROPHILIC PROTECTIVE LAYER AND METHOD FOR PRODUCING SAME LG CHEMICAL LTD (KR) 2018-10-24 EP disclosed
US-8770414-B2 Reverse osmosis membrane including ultra-hydrophilic passivation layer and method of manufacturing the same LG CHEM, LTD. (KR) 2014-07-08 US disclosed
EP-2722101-A2 REVERSE-OSMOSIS MEMBRANE HAVING AN ULTRA-HYDROPHILIC PROTECTIVE LAYER AND METHOD FOR PRODUCING SAME LG Chem, Ltd. (KR) 2014-04-23 EP disclosed
US-20130284663-A1 REVERSE OSMOSIS MEMBRANE INCLUDING ULTRA-HYDROPHILIC PASSIVATION LAYER AND METHOD OF MANUFACTURING THE SAME LG CHEM, LTD. (KR) 2013-10-31 US disclosed
US-8142953-B2 Hydrophilic adjuvant LG CHEM, LTD. (KR) 2012-03-27 US disclosed
US-20100167168-A1 Hydrophilic Adjuvant LG CHEM, LTD. (KR) 2010-07-01 US disclosed
WO-2007069867-A1 HYDROPHILIC ADJUVANT LG CHEM, LTD (KR) 2007-06-21 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100167168-A1 Hydrophilic Adjuvant CD44, CD74, LY96 INPPL1 311/4885INPP5A 1668/4885INPP5B 652/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.